Professional Documents
Culture Documents
Pain Management - Lecture 4
Pain Management - Lecture 4
Pain Management - Lecture 4
Non-Opioid Treatments
Learning Objectives
Aquamin
Boswellia (Frankincense Extracted from)
Wild, Sweet, Winter, & Sour Cherries
Ginger
Ginseng (American, Panax/Asian, or Siberian)
Kava Kava
Valerian Root
St. John’s Wort
Devil’s Claw
Vitamin B & Vitamin D
o Low Vitamin B/D levels lead to increased pain & decreased immunity
Caution: Drug Interactions
L-methylfolate
Serotonin (5HT)
Folate (Natural)
Dihydrofolate Tetrahydrofolate L-methylfolate Norepinephrine
or Folic Acid MTHFR BBB
(DHF) (THF) (Bioactive) (NE) Dopamine
(Synthetic)
(DA)
Amphetamine Products
• Controversial, Overstimulation of D/NE
• Similar MOA in ADHD treatment
Stimulants
Caffeine
Product Caffeine
• 1980’s Studies showed 40% Efficacy of APAP (~mg)
12oz. Starbucks® Cup of Joe 250
• Other studies showed adjunctive Cup of Decaf Joe 5
Al-Ghamdi AS, et al. Botulinum Toxin: Non Cosmetic & Off-Label Dermatological Uses. J Derm & Derm Surg 19 (2015) 1-8.
Botulinum Toxins
Products
o ONAbotulinumtoxinA (Botox®)
100 Unit & 200 Unit Vials
o ABObotulinumtoxinA (Dysport®)
300 Unit & 500 Unit Vials
o INCObotulinumtoxinA (Xeomin®)
50 Unit & 100 Unit Vials
o RIMAbotulinumtoxinB (Myobloc®)
2,500 U/mL, 5,000 U/mL, & 10,000 U/mL Vials
Typical Treatments
• Muscle Stiffness (Neck, elbow, wrist, & fingers)
• Headaches
Lidocaine
Transdermal Treatments
Lidocaine Mechanism of Action (MOA): Decreases frequency (not duration) of Na Channel opening
Prescription (Rx)
Lidocaine 5% Patch (Lidoderm®)
o Up to 3 patches, 12 hours on & 12 hours off
o 40% Released in 1st Hour, then will release for almost 5 days
Over-The-Counter (OTC)
Lidocaine 4% Patches
o Icy/Hot® (+ Menthol): Apply 1 patch up to every 12 hours
Lidocaine
Transdermal Treatments
Over-The-Counter (OTC)
o 0.5% to 5.0%
o Dentinox, Jogel, Doxiproct, etc …
Prescription (Rx)
o Lidocaine 5% Ointment
o Eutectic Mixture of Local Anesthetics (EMLA® Rx Cream)
Lidocaine 2.5% & prilocaine 2.5% (25mg each per 1g)
Apply with occlusion for 1-2 hours, remove, then pain relief lasts 1-2 hours
Topical Treatments
Counterirritants
o MOA: Flood pain/touch sensory channels (TRP-V1/PA1/M8)
o Examples: Menthol, methyl salicylate, eucalyptus oil, turpentine oil, & camphor
o Products: Icy/Hot®
Capsaicin
o Found in hot chili peppers & depletes Substance P (pain transmission)
o OTC 0.025% & 0.075% Creams & Patches
Topical Treatments
Topical NSAIDs
Patch Diclofenac epolamine 1.3%
• Dosing
o 2 g for each elbow, wrist, or hand
o 4 g for each knee, ankle, or foot
Max Dose Per Day is 32g
• Penetration Enhancers
o Isopropyl alcohol, propylene glycol, and water
Major Side Effects of NSAIDs & COX-2 Selective Inhibitors. March 2017. http://tmedweb.tulane.edu/pharmwiki/doku.php/nsaid_side_effects
NSAID Mechanisms of Action
Major Side Effects of NSAIDs & COX-2 Selective Inhibitors. March 2017. http://tmedweb.tulane.edu/pharmwiki/doku.php/nsaid_side_effects
NSAIDs
Non-Steroidal Anti-Inflammatory Drugs
NSAIDs inhibit prostaglandin biosynthesis by preventing arachidonic acid binding to
• Cyclooxygenase (COX) Enzymes 1 & 2
o Also known as Prostaglandin Endoperoxide Synthase 1 & 2
o Also known as prostaglandin G/H synthase 1 & 2
Cox-1
COX-1
• Expressed in nearly all cells but mainly functioning in the GI tract, kidneys, & platelets
• Produces thromboxane & prostacyclin in equal amounts, maintaining a balance
COX-2
• Expressed in the brain, kidneys, & blood vessels (i.e. the areas most susceptible to Cox-2
thrombotic events)
• Expression of COX-2 can be induced by cytokine release due to injury or inflammation
NSAID Mechanisms of Action
Feldman M & McMahon A. Do Cyclooxygenase-2 Inhibitors Provide Benefits Similar to Those of Traditional Nonsteroidal Anti-Inflammatory Drugs, with Less Gastrointestinal Toxicity? Ann Intern Med. 2000;132:134-143.
NSAID Mechanisms of Action
Feldman M & McMahon A. Do Cyclooxygenase-2 Inhibitors Provide Benefits Similar to Those of Traditional Nonsteroidal Anti-Inflammatory Drugs, with Less Gastrointestinal Toxicity?
Ann Intern Med. 2000;132:134-143.
The 4 A’s of Cox Inhibition